Abbott Laboratories (ABT) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Abbott Laboratories (ABT:NYSE), powered by AI.

Current Price
$102.87
Market Cap
178.9B
Sector
Healthcare
What is the Abbott Laboratories stock price forecast?

Abbott Laboratories is currently trading at $102.87. View real-time AI analysis on Alpha Lenz.

What is Abbott Laboratories insider trading activity?

View the latest insider trading data for Abbott Laboratories on Alpha Lenz.

What is Abbott Laboratories's P/E ratio?

View Abbott Laboratories's valuation metrics on Alpha Lenz.

Abbott Laboratories

$102.87
NYSEABT
Ask about Abbott Laboratories's future dividend policy...

Company Overview

Abbott Laboratories, a globally renowned company, specializes in the development and production of healthcare and medical products. Founded in 1888 and headquartered in Abbott Park, Illinois, Abbott is a pivotal entity in the healthcare sector. The company provides essential products spanning diagnostics, medical devices, nutritional products, and branded generic pharmaceuticals. Notably, Abbott's extensive diagnostic solutions include immunoassays and molecular diagnostics, crucial for medical testing and healthcare management. Its medical devices division produces cardiovascular and neuromodulation products, enhancing patient care across diverse medical practices. Abbott’s nutritional segment, featuring well-known brands like Similac and Ensure, supports health and wellness across various demographics. Serving markets globally, Abbott Laboratories plays a critical role in advancing healthcare infrastructure and delivering innovative solutions that address evolving health challenges worldwide. As a significant player in the life sciences field, Abbott's contributions significantly influence patient outcomes and healthcare delivery systems.

CEOMr. Robert B. Ford
SectorHealthcare
IndustryMedical Devices
Employees114,000

Company Statistics

(FY 2025)

Profile

Market Cap$178.88B
RevenueN/A
Shares Out0.00
Employees114,000

Margins

GrossN/A
EBITDAN/A
OperatingN/A
Pre-TaxN/A
NetN/A

Valuation

P/EN/A
P/BN/A
EV/SalesN/A
EV/EBITDAN/A
P/FCFN/A

Growth (CAGR)

Rev 3YrN/A
Rev 5YrN/A
Op Inc 3YrN/A
Op Inc 5YrN/A
Net Inc 3YrN/A
Net Inc 5YrN/A

Returns

ROAN/A
ROEN/A
ROICN/A

Financial Health

Cash & Cash EquivalentsN/A
Net DebtN/A
Debt/EquityN/A
Interest CovN/A
Ask Alpha Chat

Frequently Asked Questions

Alpha Lenz
Singapore
CEO: Kyungtae Kim | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2025 Treasurer. All rights reserved.
Abbott Laboratories (Healthcare) Stock Forecast & Analysis $102.87 | Alpha Lenz